To overcome the limitations of solid tumor treatment and to explore safer and more effective CARs for the treatment of NSCLC, we designed a modified EGFR CAR-E27-CCR6, which can secrete PD1 single-chain scFv E27 and express the chemokine receptor CCR6. The gene discussed is CCR6; the disease is non-small cell lung carcinoma.